www.arsiapharmaceuticals.info

Arsia Therapeutics

Site title of www.arsiapharmaceuticals.info is Arsia Therapeutics

World ranking 0 altough the site value is $0. arsiapharmaceuticals.info IP is 184.168.221.27 on WEBrick/1.3.1 (Ruby/2.2.0/2014-12-25) server works with 844 ms speed. The charset for this site is utf-8.

Web site description for arsiapharmaceuticals.info is Arsia Therapeutics helps produce high-concentration, low-viscosity pharmeceuticals, enabling biologics to be administered by subcutaneous injection.

INFORMATION FOR arsiapharmaceuticals.info
  • Site Title : Arsia Therapeutics
  • Charset : utf-8
  • Page Speed : 844 ms
  • Site Host : www.arsiarx.com
  • Site IP : 184.168.221.27
  • Site Server : WEBrick/1.3.1 (Ruby/2.2.0/2014-12-25)
  • Site Language : en
  • Google Analytic Code : 66617218-1
Security Status
Social Networks Activity
  • Facebook likes : -
  • Twitter mentions : -
  • LinkedIn mentions : -
  • Pinterest pins : -
  • StumbleUpon views : -
Alexa Global Rank
Alexa Search Traffic
KEYWORDS DENSITY (www.arsiapharmaceuticals.info)
  • Keywords Using Count Use Rate(%)
  • arsia 17 times 7.08
  • news 7 times 2.92
  • more 7 times 2.92
  • read 6 times 2.50
  • therapeutics 5 times 2.08
  • 2015 5 times 2.08
  • with 4 times 1.67
  • subcutaneous 4 times 1.67
  • research 3 times 1.25
  • biogen 3 times 1.25
  • hemophilia 3 times 1.25
  • biologics 3 times 1.25
  • technology 2 times 0.83
  • which 2 times 0.83
  • patients 2 times 0.83
  • this 2 times 0.83
  • about 2 times 0.83
  • schulman 2 times 0.83
  • kendall 2 times 0.83
  • boston 2 times 0.83
  • become 2 times 0.83
  • companies 2 times 0.83
  • presents 2 times 0.83
  • development 2 times 0.83
  • delivery 2 times 0.83
  • cambridge 2 times 0.83
  • startup 2 times 0.83
  • drugs 2 times 0.83
  • that 2 times 0.83
  • collaboration 2 times 0.83
  • interactions 2 times 0.83
  • between 2 times 0.83
  • molecules 2 times 0.83
  • spotlight 2 times 0.83
  • press 1 times 0.42
  • partnering 1 times 0.42
  • contact 1 times 0.42
  • envision 1 times 0.42
  • world 1 times 0.42
  • medicines 1 times 0.42
Link Analyse (www.arsiapharmaceuticals.info
  • Text Link Rel Target
  • who we are http://www.arsiarx.com/team_members
  • technology http://www.arsiarx.com/about
  • subcutaneous solution http://www.biocentury.com/biotech-pharma-news/emergingcompany/2015-12-14/arsia-is-reducing-biologics-viscosity-to-enable-subcutaneous-delivery-a04 nofollow blank
  • stat http://statnews.com nofollow blank
  • read more http://www.statnews.com/2015/12/24/2016-kendall-square-biotech/ nofollow blank
  • press http://www.arsiarx.com/press
  • partnering http://www.arsiarx.com/partnering
  • news about arsia /press
  • how /about
  • contact us http://www.arsiarx.com/contact
  • boston globe www.bostonglobe.com nofollow blank
  • biocentury http://www.biocentury.com nofollow blank
  • big3bio http://boston.big3bio.com/ nofollow blank
  • arsiatherapeutics http://www.arsiarx.com/
  • arsia in the spotlight http://boston.big3bio.com/2014/06/18/arsia-therapeutics-profile-janssen-labs-10x-update-2/ nofollow blank
  • all arsia news /press
RESPONSE (www.arsiapharmaceuticals.info)
  • Cache-Control : max-age=0, private, must-revalidate
  • Connection : keep-alive
  • Content-Length : 11691
  • Content-Type : text/html; charset=utf-8
  • Date : Mon, 08 Aug 2016 10:16:03 GMT
  • ETag : W/"ec17e586afecdee06bed012629549023"
  • Server : WEBrick/1.3.1 (Ruby/2.2.0/2014-12-25)
  • Via : 1.1 vegur
  • X-Content-Type-Options : nosniff
  • X-Frame-Options : SAMEORIGIN
  • X-Request-Id : 2a37e46c-e67b-4de6-a899-67166e701fae
  • X-Runtime : 0.028531
  • X-Xss-Protection : 1; mode=block
META TAGS (www.arsiapharmaceuticals.info)
  • csrf-param : authenticity_token
  • csrf-token : h/d+vtup+qgla1mi/jdmyvigtty8sn6ffzoimvmgqiznbg48hudiay4gvfjox7+1s52bmera4mq8dmdlloxt+a==
  • viewport : width=device-width, initial-scale=1, maximum-scale=1
  • x-ua-compatible : ie=edge
H TAGS (www.arsiapharmaceuticals.info)
  • h2 : news about arsia,
  • h3 : arsia in the spotlight, cambridge startup teams up with biogen on hemophilia drugs, subcutaneous solution,
CSS FILES (www.arsiapharmaceuticals.info)
  • 1 : /assets/application-6fd2c00adbb916c2a88612a32b018c93.css
JAVASCRIPT FILES (www.arsiapharmaceuticals.info)
  • 1 : //use.fonticons.com/295276eb.js
  • 2 : /assets/application-20dd9362cd5e20af97cca9659a05375a.js
  • 3 : http://fast.fonts.net/jsapi/9b602c8e-31e8-44fe-b5e2-248d9b74d0be.js